Design of peptide ligands based on protein-protein interaction and their application to protein knockdown technology
Project/Area Number |
16K15121
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Biological pharmacy
|
Research Institution | National Institute of Health Sciences |
Principal Investigator |
Naito Mikihiko 国立医薬品食品衛生研究所, 遺伝子医薬部, 部長 (00198011)
|
Co-Investigator(Kenkyū-buntansha) |
大岡 伸通 国立医薬品食品衛生研究所, 遺伝子医薬部, 室長 (80568519)
|
Co-Investigator(Renkei-kenkyūsha) |
DEMIZU Yosuke 国立医薬品食品衛生研究所, 有機化学部, 部長 (90389180)
|
Project Period (FY) |
2016-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2017: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | プロテインノックダウン / SNIPER / ヘリカルペプチド / エストロゲン受容体 / Notch / 蛋白質分解 / ユビキチン / プロテアソーム / ペプチド / 核内受容体 / 蛋白質 |
Outline of Final Research Achievements |
We developed novel SNIPER compounds against estrogen receptor and Notch1 proteins by incorporating helical peptides, PERM3 and SAHM1, respectively, to SNIPERs as target ligands. These SNIPER compounds induced proteasomal degradation of the target proteins, and a SNIPER(Notch) suppressed the expression of c-myc, a downstream gene regulated by Notch signaling. These results indicate that functional SNIPER compounds can be developed by incorporating helical peptides as a target ligand.
|
Report
(3 results)
Research Products
(32 results)
-
-
-
-
-
[Journal Article] SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib.2017
Author(s)
Ohoka, N., Nagai, K., Shibata, N., Hattori, T., Nara, H., Cho, N. & Naito, M.
-
Journal Title
Cancer Sci
Volume: 108
Issue: 5
Pages: 1032-1041
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
-
-
[Journal Article] Targeted Degradation of Proteins Localized in Subcellular Compartments by Hybrid Small Molecules.2017
Author(s)
Okuhira, K., Shoda, T., Omura, R., Ohoka, N., Hattori, T., Shibata, N., Demizu, Y., Sugihara, R., Ichino, A., Kawahara, H., Itoh, Y., Ishikawa, M., Hashimoto, Y., Kurihara, M., Itoh, S., Saito, H. & Naito, M.
-
Journal Title
Mol pharmacol
Volume: 91
Issue: 3
Pages: 159-166
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
[Journal Article] In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs).2017
Author(s)
Ohoka, N., Okuhira, K., Ito, M., Nagai, K., Shibata, N., Hattori, T., Ujikawa, O., Shimokawa, K., Sano, O., Koyama, R., Fujita, H., Teratani, M., Matsumoto, H., Imaeda, Y., Nara, H., Cho, N. & Naito, M.
-
Journal Title
J Biol Chem
Volume: 292
Issue: 11
Pages: 4556-4570
DOI
Related Report
Peer Reviewed / Int'l Joint Research / Acknowledgement Compliant
-
-
[Journal Article] Development of BCR-ABL degradation inducers via the conjugation of an imatinib derivative and a cIAP1 ligand.2016
Author(s)
Demizu, Y., Shibata, N., Hattori, T., Ohoka, N., Motoi, H., Misawa, T., Shoda, T., Naito, M. & Kurihara, M.
-
Journal Title
Bioorg Med Chem Lett
Volume: 26
Issue: 20
Pages: 4865-4869
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
-
[Presentation] Development of protein degradation inducers of oncogenic BCR-ABL protein by conjugation of ABL kinase inhibitors and IAP ligands2017
Author(s)
Norihito Shibata, Naoki Miyamoto, Katsunori Nagai, Kenichiro Shimokawa, Tomoya Sameshima, Nobumichi Ohoka, Takayuki Hattori, Yasuhiro Imaeda, Hiroshi Nara, Nobuo Cho, Mikihiko Naito
Organizer
日本薬学会第138年会
Related Report
-
[Presentation] In vivo protein knockdown by chimeric small-compound SNIPERs.2017
Author(s)
Nobumichi Ohoka, Yoko Morita, Katsunori Nagai, Kenichiro Shimokawa, Osamu Ujikawa, Ikuo Fujimori, Masahiro Ito, Youji Hayase, Keiichiro Okuhira, Norihito Shibata, Takayuki Hattori, Tomoya Samejima, Osamu Sano, Ryokichi Koyama, Yasuhiro Imaeda, Hiroshi Nara, Nobuo Cho, Mikihiko Naito
Organizer
日本薬学会第138年会
Related Report
-
-
-
-
-
-
-
-
-